ReviewMethods in molecular biology (Clifton, N.J.)2026
The Immunology of Transfusion Medicine: Past, Present, and Future.
Review in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The identification of alloantigens has been central to understanding how polymorphic variation influences transfusion safety through potential immune incompatibilities between individuals. Patients may possess naturally occurring antibodies that develop within the first few months of life or form alloantibodies after exposure to alloantigens during transfusion or pregnancy. These antibodies complicate the search for compatible blood and increase the risk of hemolytic disease of the fetus and newborn, as well as fetal and neonatal thrombocytopenia. Alloimmune mechanisms can also contribute to transfusion-related acute lung injury and transfusion-associated graft-versus-host disease. Beyond the direct complications of alloimmunity, changes in the metabolic and immunologic characteristics of transfused blood products can affect recipient immune function. In this review, we explore the historical interplay between immunology and transfusion medicine and highlight emerging preclinical and clinical insights into the field, with particular focus on the development and clinical implications of red blood cell alloimmunization.
Indexed as
Identifiers
42681404What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.